Collaborations & Partnering Opportunities

● Exclusive collaboration with Bayer Schering on selected derivatives of anti-EDB antibodies for imaging and for therapy. Two such products are currently in Phase II clinical trials.

● Collaboration with AstraZeneca on DNA-encoded chemical libraries, a discovery area which is generating combinatorial chemical libraries of unprecedented size and functionality.

● Other partnering opportunities:
To discuss collaboration opportunities in the co-development of clinical-stage products or licensing enabling technologies, please contact jane.wilton@philogen.it